Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. MIOREL (thiocolchicoside)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

MIOREL (thiocolchicoside)

Medicine - Posted on Oct 20 2017 - Updated on Jun 12 2019
Active substance (DCI)
  • thiocolchicoside
history (4)
  • 10/11/17

    MIOREL (thiocolchicoside)

    Les observations écrites transmises ne sont pas de nature à modifier l’avis de la commission de la Transparence concernant C...
    icône flèche
  • 4/11/12

    MIOREL (thiocolchicoside)

    MIOREL (thiocolchicoside)
    icône flèche
  • 9/6/06

    MIOREL (thiocolchicoside)

    MIOREL (thiocolchicoside)
    icône flèche
  • 9/7/05

    MIOREL 4 mg, gélule, plaquettes thermoformées PVC-aluminium - Boîte de 24 gélules (Code CIP : 333 988-0)

    MIOREL 4 mg, gélule, plaquettes thermoformées PVC-aluminium - Boîte de 24 gélules (Code CIP : 333 988-0)
    icône flèche
Technical information
ATC code
  • M03BX05
Manufacturer
DAIICHI SANKYO FRANCE SAS
Presentation

MIOREL 4 mg, gélule (code CIS : 65617572) : plaquette(s) de 12 gélule(s) - Code CIP : 3400933398743 / plaquette(s) de 24 gélule(s) - Code CIP : 3400933398804

All our publications
    Drug therapy Joint and rheumatic diseases Muscular diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
10ZhmgLLT7HngkZA